Table 4.
ARCO II stage | ARCO III stage | ARCO IV stage | P value | |
---|---|---|---|---|
Ts cells (CD3+CD8+) (cells/μl) | 530.4 ± 197.2 | 589.1 ± 275.1 | 423.5 ± 218.2 | 0.016 |
Th/Ts | 1.6 ± 0.9 | 1.7 ± 0.7 | 2.2 ± 1.0 | 0.011 |
The percentage of T lymphocytes (%) | 76.1 ± 7.1 | 74.4 ± 7.2 | 63.6 ± 10.4 | <0.001 |
The percentage of Ts cells (CD3+CD8+) (%) | 29.5 ± 8.1 | 27.7 ± 7.6 | 20.3 ± 5.9 | <0.001 |
| ||||
CJFH L1 type | CJFH L2 type | CJFH L3 type | ||
Ts cells (CD3+CD8+) (cells/μl) | 743.3 ± 317.7 | 528.2 ± 189.7 | 473.8 ± 221.4 | 0.001 |
Th/Ts | 1.2 ± 0.4 | 1.7 ± 0.9 | 2.1 ± 0.8 | 0.001 |
The percentage of Ts cells (CD3+CD8+) (%) | 31.7 ± 5.7 | 30.0 ± 9.6 | 23.1 ± 6.7 | <0.001 |
The percentage of Th cells (CD3+CD4+) (%) | 36.7 ± 7.1 | 43.5 ± 9.0 | 43.3 ± 9.0 | 0.038 |